Showing 1-7 of about 7 articles.
AZTherapies, Inc.
Last Patient/Last Visit completed on November 13th enabling full clinical database lock BOSTON, Nov. 18, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical...
AZTherapies, Inc.
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the dosing of the first...
AZTherapies, Inc.
BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the expansion of its...
AZTherapies, Inc.
Noah Gottdiener of Duff & Phelps and Thierry Porté of J.C. Flowers & Co. join BOD Retired Eli Lilly executive Joseph B. Kelley joins Business Advisory Board BOSTON, July 22, 2020 (GLOBE...
AZTherapies, Inc.
Cutting-edge CAR-Treg technology could have broad application across common and rare neurodegenerative diseases Smith Founder and CEO Philip Ashton-Rickardt, Ph.D. joins as SVP of Immunology ...
INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
CreAgri, Inc.
HAYWARD, Calif., May 23, 2014 (GLOBE NEWSWIRE) -- Furthering its investment the area of neuroinflammation and neuroprotection CreAgri is focusing upon a number of close relationships with selected...
Showing 1-7 of about 7 articles.
